Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04717349
Other study ID # 200126
Secondary ID 20-CH-0126
Status Recruiting
Phase
First received
Last updated
Start date April 21, 2021
Est. completion date December 2, 2039

Study information

Verified date June 10, 2024
Source National Institutes of Health Clinical Center (CC)
Contact Veronica Gomez-Lobo, M.D.
Phone (301) 435-7567
Email veronica.gomez-lobo@nih.gov
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background: Gynecologic conditions are those that are related to the reproductive system. They can be reproductive gland disorders or reproductive system tumors. They can also be inborn anomalies of the reproductive tract. Researchers want to gather data over time from a large group of young people with these conditions. Objective: To create a database about child and teenage gynecologic conditions. Eligibility: Participants of any age with known or suspected pediatric and adolescent gynecologic conditions, and their adult family members Design: Participants will be screened with a review of their medical records. Participants may have a medical history and physical exam. Participants will have blood drawn using a needle. The blood will be used for genetic tests. Participants will have saliva collected. They will spit into a small plastic container. Or their spit will be absorbed from their mouth using a small sponge. The saliva will be used for genetic tests. Participants may have samples collected from their vagina. A small cotton swab will be used to gather the samples. This procedure is optional. If participants have a surgery related to their condition, a small tissue sample will be taken. It will be stored for future research. Participants may complete optional surveys. These surveys ask about their physical and emotional health. They can choose not to answer any of the questions. Researchers will collect medical data from participants standard tests. Such tests may include blood and urine tests, X-rays, nuclear medicine scans, and other tests. Data will also be collected from standard treatments they may receive.


Description:

Study Description: The overall purpose of PAG evaluations under this protocol is to gather information over time from a large group of patients with PAG conditions to help improve our understanding of these conditions. Our aim is to create a large database of PAG conditions in presentation and variety. Objectives: Primary Objective: - Recruit a diverse population of pediatric and adult subjects with known or suspected PAG disorders in order to collect data and specimen of typical and atypical presentations of PAG disorders. - Create a large database of PAG conditions in presentation and variety.


Recruitment information / eligibility

Status Recruiting
Enrollment 11000
Est. completion date December 2, 2039
Est. primary completion date December 2, 2039
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Day to 100 Years
Eligibility - INCLUSION CRITERIA FOR PAG PATIENTS: 1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with all study procedures and availability for the duration of the study. 3. Participants with known or suspected pediatric and adolescent gynecologic conditions of any age are eligible for this protocol. INCLUSION CRITERIA FOR PAG PATIENTS OF FAMILY MEMBERS: 1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with all study procedures and availability for the duration of the study. 3. In order to be eligible to participate in this study, an individual must meet all of the following criteria: Relatives ages 18 years and older may be enrolled if clinically indicated for the diagnosis of a proband. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: 1. Any medical, physical, psychiatric, or social conditions, which, in the opinion of the investigators, would make participation in this protocol not in the best interest of the patient, will exclude participation. Patients who are critically ill, unstable, or with severe organ failure that may affect/limit the evaluation and place unsustainable demands on Clinical Center or NICHD resources will be excluded. 2. Pregnant family members

Study Design


Related Conditions & MeSH terms

  • Disease
  • Disorders of Sex Development
  • Disorders of Sex Development (DSD)
  • Pediatric and Adolescent Cancers of the Genital Tract
  • Reproductive Endocrine Conditions in Puberty
  • Structural Gynecologic Conditions Including Vulvar and Vaginal Conditions

Locations

Country Name City State
United States National Institutes of Health Clinical Center Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruit a diverse population of pediatric and adult subjects Recruit a diverse population of pediatric and adult subjects with known or suspected PAG disorders in order to collect evaluate the underlying natural history data and specimen of typical and atypical presentations of PAG disorders. Ongoing
Primary Create a large database of PAG conditions Create a large database of PAG conditions in presentation and variety. Ongoing